PYXS
PYXS clinical trials: Pyxis Oncology, Inc.
Every trial on ClinicalTrials.gov where Pyxis Oncology, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 5
- Trials linked
- 3
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
PYXS on the catalyst calendar · PYXS registry changes
- Primary completion Dec 6, 2027Sponsor estimatePhase 1/Phase 2NCT06795412Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid TumorsPyxis Oncology, Inc · Advanced Solid TumorsRecruitingPYXSLeadMRKCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 25, 2027Sponsor estimatePhase 1NCT05720117A Study of PYX-201 in Advanced Solid TumorsPyxis Oncology, Inc · Solid TumorRecruitingPYXSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2026Sponsor estimatePhase 1NCT05718557Study of PYX-106 in Solid TumorsPyxis Oncology, Inc · Solid TumorActive, not recruitingPYXSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2023ActualPhase 1NCT03389802Phase I Study of APX005M in Pediatric Central Nervous System TumorsPediatric Brain Tumor Consortium · Glioblastoma MultiformeCompletedPYXSCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 10, 2025ActualPhase 1/Phase 2NCT02706353APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic MelanomaM.D. Anderson Cancer Center · MelanomaTerminatedPYXSCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 5 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner